1.
An inactivated poliovirus vaccine using Sabin strains produced on the serum-free PER.C6® cell culture platform is immunogenic and safe in a non-human primate model
by Bockstal, Viki
Vaccine, 2018-11-12, Vol.36 (46), p.6979-6987

2.
A microneedle patch containing measles vaccine is immunogenic in non-human primates
by Edens, Chris
Vaccine, 2015, Vol.33 (37), p.4712-4718

3.
Adjuvanting an inactivated influenza vaccine with conjugated R848 improves the level of antibody present at 6months in a nonhuman primate neonate model
by Holbrook, Beth C
Vaccine, 2017-10-27, Vol.35 (45), p.6137-6142

4.
A codon-pair deoptimized live-attenuated vaccine against respiratory syncytial virus is immunogenic and efficacious in non-human primates
by Mueller, Steffen
Vaccine, 2020-03-23, Vol.38 (14), p.2943-2948

5.
Evaluation of the immunogenicity and protective efficacy of a recombinant CS6-based ETEC vaccine in an Aotus nancymaae CS6 + ETEC challenge model
by Ramakrishnan, A
Vaccine, 2021-01-15, Vol.39 (3), p.487-494

6.
Status of human monkeypox: clinical disease, epidemiology and research
by Damon, Inger K
Vaccine, 2011, Vol.29 (S4), p.D54-D59

7.
Vesicular stomatitis virus-based vaccines protect nonhuman primates against aerosol challenge with Ebola and Marburg viruses
by Geisbert, Thomas W
Vaccine, 2008, Vol.26 (52), p.6894-6900

8.
Safety and immunogenicity of a recombinant vaccine against Trypanosoma cruzi in Rhesus macaques
by Dumonteil, Eric
Vaccine, 2020-06-15, Vol.38 (29), p.4584-4591

9.
A protein-based pneumococcal vaccine protects rhesus macaques from pneumonia after experimental infection with Streptococcus pneumoniae
by Denoël, Philippe
Vaccine, 2011, Vol.29 (33), p.5495-5501

10.
Immunogenicity and efficacy of alphavirus-derived replicon vaccines for respiratory syncytial virus and human metapneumovirus in nonhuman primates
by Bates, John T
Vaccine, 2016, Vol.34 (7), p.950-956

11.
Two immunogenic recombinant protein vaccine candidates showed disparate protective efficacy against Zika virus infection in rhesus macaques
by Yang, Ruoheng
Vaccine, 2021-02-05, Vol.39 (6), p.915-925

12.
Immunogenicity of a prototype enterotoxigenic Escherichia coli adhesin vaccine in mice and nonhuman primates
by Sincock, Stephanie A
Vaccine, 2015, Vol.34 (2), p.284-291

13.
Multi-antigenic human cytomegalovirus mRNA vaccines that elicit potent humoral and cell-mediated immunity
by John, Shinu
Vaccine, 2018-03-14, Vol.36 (12), p.1689-1699

15.
Induction of neutralizing antibodies in rhesus macaques using V3 mimotope peptides
by Hessell, Ann J
Vaccine, 2016, Vol.34 (24), p.2713-2721

16.
Nucleic acid (DNA) immunization as a platform for dengue vaccine development
by Porter, Kevin R
Vaccine, 2015, Vol.33 (50), p.7135-7140

17.
Will we have new pertussis vaccines?
by Locht, Camille
Vaccine, 2018-08-28, Vol.36 (36), p.5460-5469

18.
Advancing a vaccine to prevent human schistosomiasis
by Merrifield, Maureen
Vaccine, 2016, Vol.34 (26), p.2988-2991

19.

20.
Recombinant SARS-CoV-2 spike S1-Fc fusion protein induced high levels of neutralizing responses in nonhuman primates
by Ren, Wenlin
Vaccine, 2020-07-31, Vol.38 (35), p.5653-5658
